Ari J Green
Affiliation: University of California
- Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease durationAri J Green
Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, San Francisco, CA 94143, USA
Brain 133:1591-601. 2010..Deciphering the relationships between the different types of retinal pathology may aid us in understanding the factors that drive both inflammation and tissue atrophy in multiple sclerosis...
- Heterogeneous patterns of tissue injury in NARP syndromeJeffrey M Gelfand
Department of Neurology, University of California, San Francisco, CA 94143 0114, USA
J Neurol 258:440-8. 2011..High-resolution retinal and brain imaging in NARP syndrome revealed analogous patterns of tissue injury characterized by heterogeneous areas of neuronal loss...
- Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritisA J Green
Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA
J Neurol Neurosurg Psychiatry 80:1002-5. 2009....
- Microcystic inner nuclear layer abnormalities and neuromyelitis opticaJeffrey M Gelfand
Multiple Sclerosis Center, Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA
JAMA Neurol 70:629-33. 2013..Acute optic neuritis is a cardinal manifestation of neuromyelitis optica (NMO). To our knowledge, microcystic inner nuclear layer abnormalities have not been investigated in NMO...
- Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypesJeffrey M Gelfand
University of California, San Francisco Department of Neurology, Multiple Sclerosis Center, University of California San Francisco, San Francisco, California, United States of America
PLoS ONE 7:e36847. 2012....
- Optic nerve head component responses of the multifocal electroretinogram in MSTeresa C Frohman
Department of Neurology, University of Texas Southwestern Medical Center at Dallas, USA
Neurology 81:545-51. 2013..We further sought to characterize abnormalities in ONHC responses in eyes from patients with multiple sclerosis (MS)...
- Pediatric multiple sclerosisDorothee Chabas
University of California at San Francisco, Multiple Sclerosis Center, 94117, USA
NeuroRx 3:264-75. 2006..As a result, children are receiving adult therapies in an arbitrary manner and our understanding of pediatric treatment effect and tolerability is limited. Available data on tolerability of approved drugs for adults is reviewed...
- Post-traumatic epidermoid cyst presenting with headacheA J Green
Department of Neurology, University of California San Francisco, CA 94143 0114, USA
Neurology 64:1657. 2005
- Fingolimod treatment in multiple sclerosis leads to increased macular volumeRachel Nolan
Multiple Sclerosis Center, UCSF Department of Neurology, San Francisco, CA, USA
Neurology 80:139-44. 2013..To determine whether fingolimod, an oral sphingosine-1-phosphate receptor modulator approved for treatment of multiple sclerosis (MS), generally leads to increased retinal tissue volume...
- Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective studyShiv Saidha
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Lancet Neurol 11:963-72. 2012..We aimed to determine whether MMO of the INL, and increased thickness of the INL are associated with disease activity or disability progression...
- Microcystic macular oedema in multiple sclerosis is associated with disease severityJeffrey M Gelfand
Multiple Sclerosis Centre, University of California, San Francisco, Department of Neurology, 400 Parnassus Ave, San Francisco, CA 94143 0114, USA
Brain 135:1786-93. 2012..These findings also have implications for clinical monitoring in patients with multiple sclerosis on sphingosine 1-phosphate receptor modulating agents...
- Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosisSergio E Baranzini
Department of Neurology, University of California, San Francisco, CA 94143 0435, USA
Hum Mol Genet 18:767-78. 2009..Gene ontology-based analysis shows a functional dichotomy between genes involved in the susceptibility pathway and those affecting the clinical phenotype...
- Progressive multifocal leukoencephalopathy in a patient treated with natalizumabAnnette Langer-Gould
Department of Neurology, Stanford University School of Medicine, Stanford, Calif, USA
N Engl J Med 353:375-81. 2005..The patient was treated with systemic cytarabine, and two months later, his condition had improved...
- Vitamin D in African Americans with multiple sclerosisJ M Gelfand
Department of Neurology, UCSF Multiple Sclerosis Center, San Francisco, CA, USA
Neurology 76:1824-30. 2011..To evaluate whether vitamin D is associated with multiple sclerosis (MS) status and disease severity in African Americans...
- Suprasellar germinoma and late perioptic seedingL S Pereira
Department of Ophthalmology, University of California, San Francisco, CA 94143, USA
Eur J Ophthalmol 18:159-61. 2008..To report an unusual case of optic nerve seeding 12 years following treatment of a suprasellar germinoma...